ClinicalTrials.Veeva

Menu

Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma (PSMA,ASL,PET)

T

The Second Hospital of Lanzhou University

Status

Completed

Conditions

Glioblastoma

Treatments

Diagnostic Test: glioblastoma

Study type

Observational

Funder types

Other

Identifiers

NCT06600399
23JRRA1625 (Other Grant/Funding Number)
JZhang-1990

Details and patient eligibility

About

Evaluating the relationship between prostate-specific membrane antigen positron emission tomography and arterial spin labeling perfusion imaging, and the correlation with prostate-specific membrane antigen expressed on glioblastoma microvascular.

Enrollment

26 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Newly diagnosed or recurrent glioblastoma;
  • Adult (≥18 years old);

Exclusion criteria

  • The patient has a serious underlying disease or mental illness and is unable to cooperate with the imaging examination;
  • Have received systematic chemotherapy;
  • The image data is of poor or incomplete quality;
  • pregnant women;

Trial design

26 participants in 1 patient group

Correlation between PSMA PET and ASL
Description:
The relationship between multimodal images
Treatment:
Diagnostic Test: glioblastoma

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems